Home › Funds › Octagon Capital Advisors LP › CNTX

Octagon Capital Advisors LP position in CNTX

CONTEXT THERAPEUTICS INC · Health Care

Octagon Capital Advisors LP reported holding 3,050,000 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 0.15% of its reported portfolio and ranking #26 among its reported holdings. Octagon Capital Advisors LP has disclosed CNTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)3.05M sh
Reported value held$1.69M
Portfolio Weight0.15%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's CNTX position evolved

Octagon Capital Advisors LP first disclosed a stake in CNTX in Q1 2026 at 5,250,000 shares (US$13.8M). Across 2 filings, Octagon Capital Advisors LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,050,000 shares valued at US$1.7M — a reduction of -2,200,000 shares quarter over quarter.. Notable position changes include a 42% trim in Q2 2026 (shares fell 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 5.25M $13.76M New
Q2 2026 3.05M $1.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNTX and 13F data

CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$4.1M), Avidity Partners Management LP (US$2.8M), Blue Owl Capital Holdings LP (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNTX

All CNTX fund holders →

FAQ

How long has Octagon Capital Advisors LP held CNTX?

Octagon Capital Advisors LP has disclosed CNTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Octagon Capital Advisors LP's current position in CNTX?

As of Q2 2026, Octagon Capital Advisors LP holds 3.05M shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $1.69M, representing 0.15% of its reported portfolio and ranking #26.

Has Octagon Capital Advisors LP been buying or selling CNTX?

In the latest 13F filing (Q2 2026), Octagon Capital Advisors LP reduced its position in CNTX.

Which other funds hold CNTX?

Other major institutional holders of CNTX include Nextech Invest Ltd., Avidity Partners Management LP, Blue Owl Capital Holdings LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.